Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment

Călugăru, Dan; Călugăru, Mihai

doi:10.1007/s00417-018-3901-4

Cited by 4 publications

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In DME patients, higher baseline hyperreflective foci levels indicate therapy response as measured by VA improvement and CRT decrease after three months [18] . Fluorescein Angiography When OCT angiography is not available [1] , fluorescein angiography plays important role in identifying treatment failure or inadequate response [19] , identifying the foveal avascular zone [1] , guiding supplemental laser therapy [20] and diagnosing of co-existing peripheral DR [1] . In order to evaluate the central and peripheral retina, fluorescein angiography may be employed.…”

Section: How To Detect Diabetic Macular Edemamentioning

confidence: 99%

Guidelines from an expert panel for the management of diabetic macular edema in the Malaysian population

Ngah¹,

Mohamed²,

Aziz³

et al. 2023

Int J Ophthalmol

View full text Add to dashboard Cite

AIM: To derive a Malaysia guideline and consensus as part of the Malaysia Retina Group’s efforts for diagnosis, treatment, and best practices of diabetic macular edema (DME). The experts’ panel suggests that the treatment algorithm to be divided into groups according to involvement the central macula. The purpose of DME therapy is to improve edema and achieve the best visual results with the least amount of treatment load. METHODS: On two different occasions, a panel of 14 retinal specialists from Malaysia, together with an external expert, responded to a questionnaire on management of DME. A consensus was sought by voting after compiling, analyzing and discussion on first-phase replies on the round table discussion. A recommendation was deemed to have attained consensus when 12 out of the 14 panellists (85%) agreed with it. RESULTS: The terms target response, adequate response, nonresponse, and inadequate response were developed when the DME patients’ treatment responses were first characterized. The panelists reached agreement on a number of DME treatment-related issues, including the need to classify patients prior to treatment, first-line treatment options, the right time to switch between treatment modalities, and side effects associated with steroids. From this agreement, recommendations were derived and a treatment algorithm was created. CONCLUSION: A detail and comprehensive treatment algorithm by Malaysia Retina Group for the Malaysian population provides guidance for treatment allocation of patients with DME.

show abstract